| Name | Sav-on Pharmacy #138 |
|---|---|
| Organization Name | Albertsons Llc |
| Location | 590 E 17th St, Idaho Falls, Idaho 83404 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 523-1090 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the second Series paper, Paralympic medicine, Nick Webborn of the British Paralympic Association and Peter Van de Vliet of the International Paralympic Committee Medical and Scientific Department, outline some of the issues that arise for health-care professionals when maintaining health in elite athletes with a variety of impairments.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.
A pandemic of ailments called the "allergic march" - the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood - has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.
› Verified 3 days ago
| NPI Number | 1023064946 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | SAV-ON PHARMACY #0138 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 590 E 17th St, Idaho Falls, ID 83404 |
| Phone Number | 208-523-1090 |
News Archive
In the second Series paper, Paralympic medicine, Nick Webborn of the British Paralympic Association and Peter Van de Vliet of the International Paralympic Committee Medical and Scientific Department, outline some of the issues that arise for health-care professionals when maintaining health in elite athletes with a variety of impairments.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.
A pandemic of ailments called the "allergic march" - the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood - has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.
› Verified 3 days ago
News Archive
In the second Series paper, Paralympic medicine, Nick Webborn of the British Paralympic Association and Peter Van de Vliet of the International Paralympic Committee Medical and Scientific Department, outline some of the issues that arise for health-care professionals when maintaining health in elite athletes with a variety of impairments.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Working with human immune cells in the laboratory, Johns Hopkins researchers report they have identified a critical cellular "off" switch for the inflammatory immune response that contributes to lung-constricting asthma attacks.
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.
A pandemic of ailments called the "allergic march" - the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood - has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2222 Teton Plz, Idaho Falls, Idaho 83404 Phone: (208) 523-0402 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2188 Channing Way, Idaho Falls, Idaho 83404 Phone: (208) 523-2700 | |
Walgreens #5839 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 535 E 17th St, Idaho Falls, Idaho 83404 Phone: (208) 542-4569 | |
Sav-on Pharmacy #138 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 590 E 17th St, Idaho Falls, Idaho 83404 Phone: (208) 523-1090 | |
Prescription Center Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2252 Coronado St, Idaho Falls, Idaho 83404 Phone: (208) 523-3360 |